Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of targeted radiotracers. The importance of the target to a key disease should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.
| YEAR | Impact Factor |
|---|---|
| 2023-24 | 3.6 |
| 2022 | 3.1 |
| 2021 | 2.947 |
NUCLEAR MEDICINE AND BIOLOGY, 0969-8051, 1986-ongoing, Biochemistry, Genetics and Molecular Biology,Medicine.